See the DrugPatentWatch profile for vascepa

Based on the information available, there isn't a specific set insurance savings for Vascepa (icosapent ethyl) that can be cited. The cost of Vascepa can vary depending on several factors, including the specific insurance plan, the pharmacy where the prescription is filled, and any applicable discounts or assistance programs.

Vascepa is a prescription medication approved to reduce the risk of cardiovascular events in certain high-risk patients. The drug is manufactured by Amarin Pharma, Inc. According to DrugPatentWatch.com, Vascepa's patent expired in December 2020 [1], which may lead to generic versions becoming available and potentially affecting the drug's cost.

Some pharmaceutical companies may offer patient assistance programs to help offset the cost of their medications for eligible patients. Amarin, the manufacturer of Vascepa, provides a patient savings program called Vascepa Savings [2]. This program offers eligible patients a savings card that can reduce their out-of-pocket costs for Vascepa. Patients can visit the Vascepa Savings website to learn more about the program and check their eligibility.

In summary, the cost of Vascepa can vary, and there is no set insurance savings that can be provided. Patients are encouraged to explore potential assistance programs, like Vascepa Savings, to help reduce their out-of-pocket costs.

Sources:

1. DrugPatentWatch.com. Vascepa (icosapent ethyl) [Internet]. Available from: https://www.drugpatentwatch.com/drugs/vascepa
2. Vascepa Savings. Vascepa Savings Program [Internet]. Available from: https://www.vascepa.com/savings/